Idea Proposed/Formulated by: Dr L Boominathan Ph.D.
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
Citation: Boominathan, MiRNA-based therapy for Cardiac Ischemic injury: MiRNA-331-3p decreases infarct size and remodelling and augments cardiac function via down regulation of its target gene, 1/March/2016, 16.30, http://genomediscovery.org
Significance: This study suggests that MiRNA-331-3p, by decreasing the expression of its target gene, may enhance cardiac function. Thus, pharmacological formulations encompassing “MiRNA-331-3p or its activators“ may be used to treat Cardiac Ischemic injury.
Web: http://genomediscovery.org
Courtesy: When you cite drop us a line at info@genomediscovery.org
Undisclosed information: How MiRNA-331-3p protects against Cardiac Ischemic injury.
Amount: $500*